09.03.2006 18:00:00

Valeant Pharmaceuticals Signs Courteney Cox as Kinerase(R) Spokesperson

Valeant Pharmaceuticals International (NYSE:VRX) todayannounced the signing of actress Courteney Cox to a one-year contractextension to serve as the exclusive spokesperson for the company'sKinerase brand in the United States and Europe. Terms of the agreementwith Cox were not disclosed but the actress will be promoting thebrand, and also will be participating in the development of Kineraseline product extensions.

"We are excited that Courteney has agreed to continue ourpartnership," said Wesley P. Wheeler, Valeant's president, NorthAmerica and Global Commercial Development. "She has been a wonderfuladdition to the team and we look forward to her involvement as wecontinue to grow the Kinerase line of products."

Kinerase was spotlighted recently on the television show, EXTRA!,as they joined Cox from the set of the Kinerase photo shoot. Anadvertising campaign will be launched in April, featuring Cox andKinerase in publications such as "InStyle." She also has agreed to alimited number of personal appearances.

"I love the Kinerase product and I have thoroughly enjoyed workingwith the Valeant team, which is why I agreed to a new contract toserve as the Kinerase spokesperson," said Cox. "I've been approachedby more than a hundred skin care and cosmetics brands to promote theirproducts. I never even considered promoting any product until Idiscovered Kinerase. It simply works."

Recently, Valeant Pharmaceuticals introduced three new products,Kinerase(R) Hydrating Antioxidant Mist, Under Eye Rescue and LipTreatment, to the Kinerase family of skin care products. OtherKinerase products include Kinerase Cream, Kinerase C6 PeptideIntensive Treatment, Kinerase Gentle Daily Cleanser, Kinerase Lotion,Kinerase Cream with SPF 15, and Kinerase Intensive Eye Cream.

Kinerase is the fastest-growing brand in the professional skincare category, according to the Kline Report on Professional Skin CareProducts, published in February 2006. The key ingredient in Kineraseis Kinetin, a nature-identical plant growth factor that allows theskin to retain more moisture, making skin feel firmer, healthier, andimproving its overall appearance. In a 24-week study of KineraseLotion, 90 percent of participants reported an improvement in thetexture of their skin and 87 percent reported an overall improvementin the appearance of their skin.

About Valeant:

Valeant Pharmaceuticals International is a global, research-basedspecialty pharmaceutical company that discovers, develops,manufactures and markets a broad range of pharmaceutical products.More information about Valeant can be found at www.valeant.com.

Kinerase is a registered trademark of Valeant PharmaceuticalsInternational or its related companies. For information on Kinerasevisit www.kinerase.com.

JETZT DEVISEN-CFDS MIT BIS ZU HEBEL 30 HANDELN
Handeln Sie Devisen-CFDs mit kleinen Spreads. Mit nur 100 € können Sie mit der Wirkung von 3.000 Euro Kapital handeln.
82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren.

Nachrichten zu Valeant Pharmaceuticals International Inc.mehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Valeant Pharmaceuticals International Inc.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Indizes in diesem Artikel

S&P 400 MidCap 1 854,40 -0,45%